GATE BT 2021 • Q17 MCQ • 1 Mark

Section 2: General Biotechnology

Biomolecules, enzyme kinetics

Subtopic: Fundamentals of Biomolecules, enzyme kinetics

Question Statement:

Which one of the following statements is INCORRECT about hybridoma production?

Options:

  • (A) Hybridoma cells can use hypoxanthine and thymidine
  • (B) DNA synthesis in myeloma cells is blocked by aminopterin
  • (C) Hybridoma cells are made to produce polyclonal antibodies
  • (D) Polyethylene glycol is used to fuse myeloma cells to B-cells

Official Answer Key:

C

Step-by-Step Solution & Explanation

### **Official Solution & Concept Analysis (GATE BT 2021 Q.17)** **1. Governing Concept**: - **Topic**: Immunology & Hybridoma Technology - Hybridoma production principles: - Spleen B-cells (producing specific antibodies) are fused with myeloma cells (immortal) using polyethylene glycol (PEG). - Selected hybridomas are single-cell cloned to secrete identical, epitope-specific **monoclonal antibodies (mAbs)**, NOT polyclonal antibodies. - Aminopterin blocks the de novo nucleotide synthesis pathway in myeloma cells. - Hybridoma cells survive by utilizing hypoxanthine and thymidine via the salvage pathway (HGPRT provided by B-cells). **2. Option Analysis**: - **Option (A) is CORRECT statement**: Hybridomas express HGPRT and TK, utilizing the salvage pathway. - **Option (B) is CORRECT statement**: Aminopterin inhibits dihydrofolate reductase, blocking de novo synthesis. - **Option (C) [Hybridoma cells are made to produce polyclonal antibodies] is INCORRECT (Statement false, hence the CORRECT option)**: Hybridomas are explicitly isolated to produce **monoclonal** antibodies. - **Option (D) is CORRECT statement**: PEG is the standard chemical fusogen. **3. Final Answer**: - **Correct Choice**: **C**

Practice This in Real CBT Exam Interface

Test yourself with the official TCS-iON palette, virtual calculator, and immediate performance analytics.

Launch CBT Mock Test